Portal de Periódicos da CAPES

Drug Repurposing: New Treatments for Zika Virus Infection?

2016; Elsevier BV; Volume: 22; Issue: 11 Linguagem: Inglês

10.1016/j.molmed.2016.09.006

1471-499X

Feixiong Cheng, James L. Murray, Donald H. Rubin,

Virology and Viral Diseases

To date, no antiviral agents have been approved for treating Zika virus (ZIKV) infection. Two recent drug-repurposing studies published in Cell Host & Microbe and Nature Medicine demonstrated that screening FDA-approved drugs for antiviral activity is a promising strategy for identifying therapeutics with novel activity against ZIKV infection.